Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Johnson & Johnson (JNJ) Profit Margins

Over the twelve months to 2026-09-27, Johnson & Johnson (JNJ) had gross margin 67.6%, net margin 16.2%, free cash flow margin 20.7%, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-09-27 · read by EquiReason

JNJJohnson & JohnsonFollow JNJ — free
Drug Manufacturers - General · Healthcare
—
Price chart with a free account
Market cap
635.1B
P/E TTM
40.0
Dividend yield
2.0%
52-week
—
Next earnings
26 Jan, in 94 days
LineFY2018
Dec 18
FY2019
Dec 19
FY2020
Jan 21
FY2021
Jan 22
FY2022
Jan 23
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Sep 26
Trend
Gross margin66.8%66.4%65.6%70.3%69.3%68.8%69.1%67.9%67.6%
Net margin18.8%18.4%17.8%26.5%22.4%41.3%15.8%28.5%16.2%
FCF margin22.7%24.3%24.4%25.1%21.5%21.4%22.3%20.9%20.7%

USD billions · SEC XBRL

Johnson & Johnson — questions

What is Johnson & Johnson's gross margin?
67.6% over the twelve months to 2026-09-27.
What is Johnson & Johnson's net profit margin?
16.2% over the twelve months to 2026-09-27.

Every figure on this page comes from Johnson & Johnson's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.